Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000914190-09-000711
Filing Date
2009-10-29
Accepted
2009-10-29 14:10:00
Documents
1
Period of Report
2009-09-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 18864
  Complete submission text file 0000914190-09-000711.txt   20777
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address UCLA SCHOOL OF MEDICINE 10833 LE CONTE 66-118 CHS BOX 951738 LOS ANGELES CA 9095-1738
Business Address
Belldegrun Arie (Reporting) CIK: 0001296549 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-34058 | Film No.: 091144108